Published source snapshot
Poly-Zyme 022
LifeLink · US label facts
Label IDlbl_dsld_11824_81df01cd25aa1cad
Serving size6 Tablet(s)
Serving formTablet(s)
Retrieved
Scope: source-market status describes the source record, not live availability. Quantities below are label facts and deterministic arithmetic, not a product recommendation.
Original facts and normalized results
| Ingredient | Original label quantity | Requested normalization | Measurement object |
|---|---|---|---|
| Papain DSLD row path: root.0; DSLD ingredientId: 288343 | 15 mg | 15 mg / as_labeled | Papain |
| Blend (non-nutrient/non-botanical) DSLD row path: root.1; DSLD ingredientId: 7831 | 12 mg | 12 mg / as_labeled | Pancreatin |
| Thymus DSLD row path: root.2; DSLD ingredientId: 38985 | 6 mg | 6 mg / as_labeled | Thymus Concentrate |
| Lactose Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 282557. | Not stated | missing_quantity | Lactose |
| Magnesium stearate Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 34937. | Not stated | missing_quantity | Magnesium Stearate |
Label statements
These are explicitly classified as label claims. They are not converted into platform-endorsed scientific conclusions.
- label_claim General Statements: All Other Content: Poly-Zyme 022 is used by cancer patients to prevent metastases, and as an antiviral by people with herpes infections, such as shingles. The tablets are enteric coated to protect the enzymes while they pass through the stomach.
- label_claim General Statements: All Other Content: An enteric-coated proteolytic enzyme formula 022
- label_claim Suggested/Recommended/Usage/Directions: Suggested Use: 6 to 20 tablets daily in divided doses or as directed by a health care professional.
Ingredient references
Reference pages provide verified source mappings. Unless a real review record exists, they remain reference-only with no medical summary or evidence grade.
Source and version
- Original record
- NIH ODS DSLD label 11824
- Local snapshot
- snap_dsld_11824_81df01cd25aa1cadc3560a8e
- Content hash
81df01cd25aa1cadc3560a8e5ef6f1bcaa4c2afe4169b8c05a7570c097513889- Source version
- Not stated
Limitations
- This record reports label facts from a US-market source snapshot, not current inventory or product safety.
- Label quantity comparisons do not establish absorption, efficacy, safety, or clinical equivalence.